LnRiLWhlYWRpbmcuaGFzLWJhY2tncm91bmR7cGFkZGluZzowfQ==
.tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom} .tb-image[data-toolset-blocks-image="835a8541e055ce4da79856a10203d561"] { max-width: 100%; } h3.tb-heading[data-toolset-blocks-heading="270746582c80dfe7513f34ae1c9848ad"]  { font-weight: bold; }  .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom} .tb-image[data-toolset-blocks-image="5d3486ac84cf49a5a5db0609e90d678f"] { max-width: 100%; } .tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="8ad3d55d50a197cf88e5d5d26adcfbf5"] { margin-bottom: -5px;grid-template-columns: minmax(0, 0.25333333333333fr) minmax(0, 0.37333333333333fr) minmax(0, 0.37333333333333fr);grid-column-gap: 10px;grid-row-gap: 5px;grid-auto-flow: row } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="8ad3d55d50a197cf88e5d5d26adcfbf5"] > .tb-grid-column:nth-of-type(3n + 1) { grid-column: 1 } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="8ad3d55d50a197cf88e5d5d26adcfbf5"] > .tb-grid-column:nth-of-type(3n + 2) { grid-column: 2 } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="8ad3d55d50a197cf88e5d5d26adcfbf5"] > .tb-grid-column:nth-of-type(3n + 3) { grid-column: 3 } .wp-block-toolset-blocks-grid-column.tb-grid-column[data-toolset-blocks-grid-column="3034fbe886c11054e95b46b09d3e4112"] { display: flex; } h1.tb-heading[data-toolset-blocks-heading="5a4e3045a9f53d6d43192d8a195d0a40"]  { font-size: 23px;font-family: Raleway;font-weight: bold; }  h1.tb-heading[data-toolset-blocks-heading="5a4e3045a9f53d6d43192d8a195d0a40"] a  { text-decoration: none; } .wp-block-toolset-blocks-grid-column.tb-grid-column[data-toolset-blocks-grid-column="f586ff7bfe1d7317c63162ec7b7039ed"] { display: flex; } .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom} .wp-block-image.tb-image[data-toolset-blocks-image="063a3899717f0005199638d2a1656d44"] { max-width: 100%; } @media only screen and (max-width: 781px) { .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom} .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom}.tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="8ad3d55d50a197cf88e5d5d26adcfbf5"] { grid-template-columns: minmax(0, 0.3333fr) minmax(0, 0.3333fr) minmax(0, 0.3333fr);grid-column-gap: 5px;grid-row-gap: 5px;grid-auto-flow: row } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="8ad3d55d50a197cf88e5d5d26adcfbf5"] > .tb-grid-column:nth-of-type(3n + 1) { grid-column: 1 } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="8ad3d55d50a197cf88e5d5d26adcfbf5"] > .tb-grid-column:nth-of-type(3n + 2) { grid-column: 2 } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="8ad3d55d50a197cf88e5d5d26adcfbf5"] > .tb-grid-column:nth-of-type(3n + 3) { grid-column: 3 } .wp-block-toolset-blocks-grid-column.tb-grid-column[data-toolset-blocks-grid-column="3034fbe886c11054e95b46b09d3e4112"] { display: flex; }  .wp-block-toolset-blocks-grid-column.tb-grid-column[data-toolset-blocks-grid-column="f586ff7bfe1d7317c63162ec7b7039ed"] { display: flex; } .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom} } @media only screen and (max-width: 599px) { .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom} .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom}.tb-grid,.tb-grid>.block-editor-inner-blocks>.block-editor-block-list__layout{display:grid;grid-row-gap:25px;grid-column-gap:25px}.tb-grid-item{background:#d38a03;padding:30px}.tb-grid-column{flex-wrap:wrap}.tb-grid-column>*{width:100%}.tb-grid-column.tb-grid-align-top{width:100%;display:flex;align-content:flex-start}.tb-grid-column.tb-grid-align-center{width:100%;display:flex;align-content:center}.tb-grid-column.tb-grid-align-bottom{width:100%;display:flex;align-content:flex-end} .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="8ad3d55d50a197cf88e5d5d26adcfbf5"] { grid-template-columns: minmax(0, 0.33333333333333fr) minmax(0, 0.33333333333333fr) minmax(0, 0.33333333333333fr);grid-column-gap: 10px;grid-row-gap: 15px;grid-auto-flow: row } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="8ad3d55d50a197cf88e5d5d26adcfbf5"] > .tb-grid-column:nth-of-type(3n + 1) { grid-column: 1 } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="8ad3d55d50a197cf88e5d5d26adcfbf5"] > .tb-grid-column:nth-of-type(3n + 2) { grid-column: 2 } .wp-block-toolset-blocks-grid.tb-grid[data-toolset-blocks-grid="8ad3d55d50a197cf88e5d5d26adcfbf5"] > .tb-grid-column:nth-of-type(3n + 3) { grid-column: 3 } .wp-block-toolset-blocks-grid-column.tb-grid-column[data-toolset-blocks-grid-column="3034fbe886c11054e95b46b09d3e4112"] { display: flex; }  .wp-block-toolset-blocks-grid-column.tb-grid-column[data-toolset-blocks-grid-column="f586ff7bfe1d7317c63162ec7b7039ed"] { display: flex; } .tb-image{position:relative;transition:transform 0.25s ease}.wp-block-image .tb-image.aligncenter{margin-left:auto;margin-right:auto}.tb-image img{max-width:100%;height:auto;width:auto;transition:transform 0.25s ease}.tb-image .tb-image-caption-fit-to-image{display:table}.tb-image .tb-image-caption-fit-to-image .tb-image-caption{display:table-caption;caption-side:bottom} } 
헬릭스미스(084990) | |||
대표이사 | 김선영, 유승신 | 대표번호 | 02)2102-7200 |
시가총액(억) | 8,052 | 사원수 | 121 |
설립 | 1996/11/21 | 상장 | 2005/12/29 |
주소 | 서울특별시 강서구 마곡중앙8로7길 21 | ||
홈페이지 | https://www.helixmith.com/ | ||
종목테마 | 의료/바이오 | ||
PER(배) | N/A | PBR(배) | 3.44 |
EPS(원) | -3,832 | ROE(%) | -64.98 |
주주현황 | 김선영(외 12인) 10.75% |
발행주식수 | 34,265,714 |
수익률(1M/3M/6M/1Y) | -2.49/ -26.91/ -20.30/ -52.50 |
액면가 | 500 |
배당수익률 | - |
기간 | 20년 | 19년 | 18년 |
매출액 | 43 | 45 | 31 |
순이익 | -839 | -1084 | -287 |
영업이익 | -711 | -417 | -200 |
자산총계 | - | 3714 | 2842 |
자본총계 | - | 1991 | 1380 |
부채총계 | - | 1724 | 1462 |
날짜 | 내용 |
2020/04/01 | 대표이사 김선영, 유승신으로 변경 |
2019/03/27 | ㈜바이로메드 > ㈜헬릭스미스 변경 |
2018/08/10 | 사내이사 김성철 사임 |
2018/08/01 | 사내이사 김용수 사임, 김영선 단독대표이사로 변경 |
번호 | 공시대상회사 | 보고서명 | 제출인 | 접수일자 |
1 | 헬릭스미스 | 기타경영사항(특허권취득)(자율공시) | 헬릭스미스 | 2021/03/25 |
2 | 헬릭스미스 | 사업보고서 (2020.12) | 헬릭스미스 | 2021/03/25 |
3 | 헬릭스미스 | 감사보고서제출 | 헬릭스미스 | 2021/03/23 |
추가 공시 더보기
DNA 기술 기반 치료제 연구 개발
파이프라인 당뇨 치료제 개발중
천연물 의약 산업 및 치료제 개발
1. 다양한 치료제 개발 중
매출액은 전년 동기 대비 64% 증가했으나 비용 부담으로 영업손실이 101% 확대되었습니다. 핵심 파이프라인인 당뇨 치료제 VM202는 현재 미국 임상 3상이 진행 중에 있으며 전문 기관에서는 임상 통과와 시판허가의 윤곽이 드러날 때 투자하는 것을 추천하고 있습니다.
#2020 업데이트
2. 바이오 신약 개발 몰두 헬릭스미스
헬릭스미스는 2005년 코스닥시장에 상장했으며 DNA 기술 기반의 유전자 치료제(바이오신약 사업, 천연소재 약효 검증 사업) 사업을 영위했습니다. 현재는 다양한 임상 실험으로 신약 개발에 힘쓰고 있으나 해당 사업이 실패할 가능성이 커 투자 고위험 군에 속하는 기업입니다.